Lantheus sells SPECT business | Akumin secures new funding to fuel long-term growth | New York rad group hit with data breach

Akumin recently announced several developments intended to strengthen its finances and support the growth of its imaging and radiation oncology services. 

Lantheus has signaled that the decision to sell its SPECT business will allow the company to focus more on growing its portfolio of PET radiodiagnostics and microbubbles. 

During the breach, certain files within the group's network were accessed and copied without permission. 

This is a Class I recall, which means the FDA believes these devices could cause a serious injury or death.

The New York-based imaging company is now focused on expanding sales for the cost-effective PET-CT system it developed with Neusoft Medical Systems.

HealthExec zooms in on laws passed in Massachusetts, Oregon and California that are set to change how hedge funds interact with patient care organizations.

The CDC has gone ahead and changed its recommendations for childhood immunizations. The gnashing of teeth has only just begun.